Single-cell proteomics: potential implications for cancer diagnostics.

Area of Science:

• Oncology
• Proteomics
• Molecular Diagnostics

Background:

• Current cancer diagnostics (histopathology, mutation detection, imaging) have limitations in guiding therapy.
• Predicting patient response to cancer treatment remains challenging.
• Understanding cellular states and signaling pathways is key to identifying cancer-driving mutations.

Purpose of the Study:

• To review single-cell proteomics technologies for cancer diagnostics.
• To highlight methods adaptable for routine clinical use.
• To discuss the potential of single-cell proteomics to transform cancer care.

Main Methods:

• Focus on technologies enabling complex single-cell data collection.
• Review of methods suitable for integration into routine diagnostics.
• Discussion of current diagnostic limitations and future potential.

Main Results:

• Single-cell proteomics provides detailed molecular insights into individual tumor cells.
• Emerging technologies offer pathways for more precise cancer diagnosis.
• The potential exists to link cellular states to specific mutations and therapeutic vulnerabilities.

Conclusions:

• Single-cell proteomics promises more accurate cancer diagnoses and personalized therapies.
• Clinical validation in trials is crucial for widespread adoption.
• This approach is poised to revolutionize cancer diagnostics and treatment alignment.